Formulation and Characterization of Triamcinolone Acetonide Acetate-Loaded Microspheres Prepared by a Static Mixing Technique
- PMID: 38847256
- DOI: 10.2174/0115672018302129240603052316
Formulation and Characterization of Triamcinolone Acetonide Acetate-Loaded Microspheres Prepared by a Static Mixing Technique
Abstract
Purpose: Reproducibility and scale-up production of microspheres through spray drying present significant challenges. In this study, biodegradable microspheres of Triamcinolone Acetonide Acetate (TAA) were prepared using a novel static mixing method by employing poly( lactic-co-glycolic acid) (PLGA) as the sustained-release carrier.
Methods: TAA-loaded microspheres (TAA-MSs) were prepared using a static mixing technique. The PLGA concentration, polyvinyl alcohol concentration (PVA), phase ratio of oil/water, and phase ratio of water/solidification were optimized in terms of the particle size, drug loading (DL), and encapsulation efficiency (EE) of TAA-MSs. The morphology of TAA-MSs was examined using Scanning Electron Microscopy (SEM), while the physicochemical properties were evaluated through X-ray diffraction (XRD), Differential Scanning Calorimetry (DSC), and Fourier Transform Infrared Spectroscopy (FT-IR). The in vitro release of TAA-MSs was compared to that of the pure drug (TAA) using a water-bath vibration method in the medium of pH 7.4 at 37°C.
Results: The formulation composition and preparation condition for the preparation of TAA-MSs were optimized as follows: the PLGA concentration was 1%, the phase ratio of oil(dichloromethane) /water (PVA solution) was 1:3, the phase ratio of water (PVA solution)/solidification was 1:2. The optimized TAA-MSs displayed spherical particles with a size range of 30-70 μm, and DL and EE values of 27.09% and 98.67%, respectively. Moreover, the drug-loaded microspheres exhibited a significant, sustained release, with 20% of the drug released over a period of 28 days. The XRD result indicated that the crystalline form of TAA in microspheres had been partly converted into the amorphous form. DSC and FT-IR results revealed that some interactions between TAA and PLGA occurred, indicating that the drug was effectively encapsulated into PLGA microspheres.
Conclusion: TAA-loaded PLGA microspheres have been successfully prepared via the static mixing technique with enhanced EE and sustained-release manner.
Keywords: PLGA; Triamcinolone acetonide acetate; drug delivery; in vitro release; microspheres; physicochemical properties..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.Pharmazie. 2011 Sep;66(9):654-61. Pharmazie. 2011. PMID: 22026119
-
Formulation Optimization and In Vitro Characterization of Granisetronloaded Polylactic-co-glycolic Acid Microspheres Prepared by a Dropping-in-liquid Emulsification Technique.Curr Drug Deliv. 2022;19(6):721-729. doi: 10.2174/1567201818666210729111646. Curr Drug Deliv. 2022. PMID: 34325634
-
Preparation and physicochemical characterization of T-OA PLGA microspheres.Chin J Nat Med. 2017 Dec;15(12):912-916. doi: 10.1016/S1875-5364(18)30007-4. Chin J Nat Med. 2017. PMID: 29329648
-
Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection.Drug Des Devel Ther. 2018 Apr 5;12:711-719. doi: 10.2147/DDDT.S151437. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29670329 Free PMC article.
-
Formulation and Evaluation of Novel Additive-Free Spray-Dried Triamcinolone Acetonide Microspheres for Pulmonary Delivery: A Pharmacokinetic Study.Pharmaceutics. 2022 Oct 31;14(11):2354. doi: 10.3390/pharmaceutics14112354. Pharmaceutics. 2022. PMID: 36365172 Free PMC article.
LinkOut - more resources
Full Text Sources
Miscellaneous